Fluorescence Microscope for Localized Assessment and Sparing of Histology in Prostate Cancer (FLASH): An International, Multicentre, Prospective Diagnostic Accuracy and Clinical Utility Study With Blinded Index-Test and Reference-Standard Readers (2026)

Government Record · Shanghai East Hospital (lead sponsor) · September 29, 2026

Shanghai East Hospital (lead sponsor), 2026-09-29: Registered (not yet recruiting) international multicentre diagnostic-accuracy study in which every prostate biopsy core is dual-stained with fluorescein sodium and methylene blue and scanned with a real-time fluorescence microscope before routine histopathology; 450 men planned.

Immediately after extraction, every core will undergo ex vivo dual staining (fluorescein sodium for 30 seconds followed by methylene blue for 30 seconds)

Shanghai East Hospital (lead sponsor), 2026-09-29: Registered (not yet recruiting) international multicentre diagnostic-accuracy study in which every prostate biopsy core is dual-stained with fluorescein sodium and methylene blue and scanned with a real-time fluorescence microscope before routine histopathology; 450 men planned. C4 (also C10). Study type: prospective diagnostic accuracy study, registered, NOT_YET_RECRUITING (estimated start 2026-12-01). N: 450 planned. International multicentre; lead sponsor Shanghai East Hospital (China). Methylene blue: 30-second ex vivo core staining after 30-second fluorescein sodium; no systemic exposure. Device: EndoScell MES-1000P. Funders/conflicts: not stated in the record. Comparator: same-core FFPE histopathology with blinded readers. Quote is a record field taken from api/v2/studies/NCT07846592 (detailed description); the human study page is client-rendered and the API record is the same federal record. Registered, no results posted.